Wy 41747

• Description:

  Wy 41747 is a long-acting Somatostatin analogue. Wy 41747 can be used for the research of diabetes mellitus[1].

• UNSPSC:

  12352209

• Target:

  Somatostatin Receptor

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/wy-41747.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@](NC([C@@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)CC2=CC=CC=C2)=O)([H])[C@H](O)C)=O)CO)=O)C(O)=O)N)=O)CC3=CN=CN3)=O)CC4=CN=CN4)=O)CC5=CC=CC=C5)=O)CC6=CC=CC=C6)N[C@@H]1CC7=CNC8=CC=CC=C78

• Molecular Formula:

  C73H92N18O16S2

• Molecular Weight:

  1541.75

• References & Citations:

  [1]Dimitriadis G, et, al. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism. 1983 Oct;32 (10) :987-92.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  [68463-41-2]